Come up with a name for your new list and we'll add to it:
Carmot Therapeutics raised a round of funding on January 20, 2010. Investors include
National Science Foundation.
Carmot Therapeutics is applying its technology, Chemotype Evolution, to address unmet chemical needs in drug discovery, focusing on high-profile targets for which drug leads have been difficult to ide…